Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Price Target Raised at Mizuho

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its price target boosted by analysts at Mizuho from $18.00 to $20.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho‘s price objective suggests a potential upside of 79.66% from the stock’s current price.

Other research analysts have also recently issued reports about the stock. Stifel Nicolaus reiterated a “hold” rating and issued a $10.00 price objective (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday. Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Barclays boosted their price objective on Senseonics Holdings, Inc. Common Stock from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Weiss Ratings upgraded Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $14.00 target price on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $14.40.

Senseonics Holdings, Inc. Common Stock Stock Performance

SENS stock traded up $1.33 during mid-day trading on Tuesday, reaching $11.13. The company had a trading volume of 3,253,934 shares, compared to its average volume of 681,334. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. The stock’s 50-day simple moving average is $9.12 and its two-hundred day simple moving average is $7.26. The stock has a market capitalization of $465.32 million, a P/E ratio of -5.02 and a beta of 1.04. Senseonics Holdings, Inc. Common Stock has a one year low of $4.79 and a one year high of $13.98.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its quarterly earnings results on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The firm had revenue of $19.56 million during the quarter. Research analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current year.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder bought 13,953 shares of the firm’s stock in a transaction on Wednesday, August 19th. The stock was bought at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares in the company, valued at $1,537,295.18. This represents a 8.87% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 4.70% of the company’s stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several large investors have recently added to or reduced their stakes in the company. StoneX Group Inc. acquired a new position in Senseonics Holdings, Inc. Common Stock in the 3rd quarter valued at approximately $128,000. Traynor Capital Management Inc. purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the 3rd quarter valued at $152,000. State of Wyoming grew its holdings in shares of Senseonics Holdings, Inc. Common Stock by 27.2% during the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock valued at $152,000 after acquiring an additional 3,199 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth $36,000. Finally, Readystate Asset Management LP purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $574,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Senseonics Holdings, Inc. Common Stock

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: Q3 revenue reached $19.6 million, up about 140% year over year. Senseonics raised its 2026 revenue outlook to $68 million–$70 million from $62 million–$66 million, above the $64.2 million consensus, and now expects full-year gross margin above 60%. Third-quarter results
• Positive Sentiment: TD Cowen raised its price target to $17 and maintained a Buy rating; HC Wainwright also reaffirmed Buy with a $14 target. TD Cowen recommendations HC Wainwright recommendations
• Neutral Sentiment: Raymond James upgraded SENS from Underperform to Market Perform, a more favorable rating but not a Buy recommendation.
• Negative Sentiment: The company reported a Q3 loss of $0.50 per share, slightly worse than the $0.49 consensus and the $0.43 loss a year earlier. Q3 earnings coverage
• Negative Sentiment: Stifel maintained Hold with a $10 target and Barclays kept Equal Weight with an $11 target—both below the cited share price, tempering the more bullish analyst views. Stifel recommendations Barclays recommendations

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc. is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application. The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.